Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog

Machine Learning Is Accelerating the Pace of Drug Development, But Good Data is Key

Posted on April 19th, 2019 by in Pharma R&D

Artificial Intelligence, Machine Learning and Deep Learning are on the tip of everyone’s tongues when it comes to acceleration of the pace of discovery The Pharma R&D market is a perfect exemplification of this phenomenon. Medical advancements enabled by such technologies have proven to significantly accelerate discovery processes, saving valuable time and money required for the development of life changing solutions. That being said, there is the reality that human beings with a passion and talent for feeding such mechanisms still and likely always will provide invaluable inputs. In short, we are not to be replaced by these advancements; rather the changes are indicative of a new era of advancement defined by “partnerships” between humans and machines.

(more…)

Government Shutdown Means New Drugs May Have to Wait – But Safety Monitoring Will Continue

Posted on January 17th, 2019 by in Pharma R&D

The partial shutdown of the U.S. government, which began just before the Christmas holiday, has been especially terrible for hundreds of thousands of federal employees who are either furloughed or working without pay. (more…)

Advances in Gene & Cell Therapy

Posted on November 6th, 2017 by in Pharma R&D

I would like to applaud the recent news about the Advisory Panel to the USA FDA’s unanimous (16-0) recommendation for allowing to further develop therapy by Spark Therapeutics Inc. (more…)

“If you gave the same NCE to two different companies……”

Posted on March 24th, 2016 by in Pharma R&D

You might think this is the opening line for a riddle, but in fact it forms the basis of IDEA Pharma’s Productive Innovation Index (PII for short), an annual ranking of the top 30 biopharmaceutical companies (more…)